Menu Close
Headshot

Tony Manderson

Director Therapeutic Goods Administration

Dr Tony Manderson is currently the Director, Scientific Operations and Management Section at the Therapeutic Goods Administration (TGA) in Australia. In this role, he is responsible for a broad policy reforms, including changes to the human cell and tissue framework (known as biologicals) and the development of revision of standards for the labelling orders, nicotine vapes, medicinal cannabis and FMT.

Before joining the TGA in 2007, Tony worked as a post-doctoral research scientist at Imperial College in London and the Institute of Molecular Biosciences in Brisbane, with a focus on complement biology, autoimmunity and macrophage biology, after obtaining my PhD in Immunology from the Australian National University in Canberra, Australia.

See Tony Manderson at this event

  • Day 3 Thursday 5 December

E-labelling as a pathway to a future Universal Label

Session objectives:

  • Share the experience of adopting e-labelling, and opportunities for further harmonization and better interoperability.
  • Open a dialogue on the concept of universal labelling, in the context of an evolving digital healthcare ecosystem highlighting its potential to streamline supply chain logistics, reduce packaging waste, and support a green economy.
  • Examine how these systems may alleviate drug shortages, enhance preparedness for future pandemics, and expedite manufacturing processes.
  • By initiating this vital conversation now, the session seeks to align direction around future digital labelling options.

Speakers